Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.
Financial Results:
Aurobindo Pharma Ltd reported Revenues for Q2FY24 of ₹7,219.00 Crores up from ₹5,739.00 Crore year on year, a rise of 25.79%.
Total Expenses for Q2FY24 of ₹6,332.00 Crores up from ₹5,273.00 Crores year on year, a rise of 20.08%.
Consolidated Net Profit of ₹752.00 Crores up 83.41% from ₹410.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹12.92, up 84.84% from ₹6.99 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.
Most Popular
Cochin Shipyard Ltd (COCHINSHIP) Q4 FY22 Earnings Concall Transcript
Cochin Shipyard Limited (NSE:COCHINSHIP) Q4 FY22 Earnings Concall dated May. 26, 2022 Corporate Participants: Madhu S Nair -- Chairman & Managing Director Jose V J -- Director Finance Analysts: Vastupal Shah
All you need to know about Antony Waste Handling Cell in one article
Can you guess the name of the company that was listed during the IPO frenzy in 2020 and is the second largest player in the Indian municipal waste management industry?
Demystifying the Leading Non-Ferrous Recycling Company of India
“Hey, how is the market doing today?” “Oh!, its falling tremendously since morning” I am sure news like these might be a common topic of discussion for you nowadays. Interestingly,